Q1 2026 Holdings
Filed 2026-05-14 | 450 holdings | $362.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cenovus Energy Inc(CVE) | COM | 15135U109 | $201.5K | 7,596 | 0.1% |
| Permian Resources Corp(PR) | CLASS A COM | 71424F105 | $201.5K | 9,453 | 0.1% |
| SM Energy Company(SM) | COM | 78454L100 | $202.1K | 6,482 | 0.1% |
| Matador RES Co(MTDR) | COM | 576485205 | $202.2K | 3,200 | 0.1% |
| Suncoke Energy Inc(SXC) | COM | 86722A103 | $202.3K | 31,071 | 0.1% |
| Westlake Corporation(WLK) | COM | 960413102 | $202.8K | 1,736 | 0.1% |
| BP PLC(BP) | SPONSORED ADR | 055622104 | $203.1K | 4,322 | 0.1% |
| California RES Corp(CRC) | COM STOCK | 13057Q305 | $204.2K | 2,950 | 0.1% |
| APA Corporation(APA) | COM | 03743Q108 | $204.8K | 4,825 | 0.1% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $204.9K | 26,786 | 0.1% |
| Sylvamo Corp(SLVM) | COMMON STOCK | 871332102 | $205.8K | 4,873 | 0.1% |
| Murphy Oil Corp(MUR) | COM | 626717102 | $206.5K | 5,007 | 0.1% |
| Cabot Corp(CBT) | COM | 127055101 | $207.1K | 2,750 | 0.1% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $209.4K | 7,016 | 0.1% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $209.6K | 7,553 | 0.1% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $210.5K | 47,095 | 0.1% |
| Anglogold Ashanti PLC(AU) | COM SHS | G0378L100 | $214.1K | 2,199 | 0.1% |
| Savara Inc(SVRA) | COM | 805111101 | $215.2K | 39,405 | 0.1% |
| Eyepoint Inc(EYPT) | COM NEW | 30233G209 | $219.8K | 17,052 | 0.1% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $220.2K | 5,474 | 0.1% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $220.6K | 38,030 | 0.1% |
| Prokidney Corp(PROK) | SHS CL A | 74291D104 | $220.9K | 123,388 | 0.1% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $221.6K | 14,299 | 0.1% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $223.7K | 40,457 | 0.1% |
| Ataibeckley Inc(ATAI) | COM SHS | 04650F101 | $225.0K | 63,563 | 0.1% |
| Uniqure NV(QURE) | SHS | N90064101 | $228.5K | 13,977 | 0.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $229.8K | 21,676 | 0.1% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $230.3K | 3,425 | 0.1% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $231.4K | 66,508 | 0.1% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $234.2K | 25,154 | 0.1% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $234.3K | 7,319 | 0.1% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $237.5K | 9,966 | 0.1% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $239.3K | 7,354 | 0.1% |
| BCP Investment Corporation(BCIC) | COM NEW | 73688F201 | $246.9K | 32,830 | 0.1% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $247.7K | 17,821 | 0.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $249.3K | 6,476 | 0.1% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $253.2K | 3,040 | 0.1% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $255.5K | 6,374 | 0.1% |
| Jade Biosciences Inc(JBIO) | COM NEW | 008064206 | $255.8K | 18,203 | 0.1% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $255.8K | 26,320 | 0.1% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $256.3K | 10,320 | 0.1% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $256.5K | 14,150 | 0.1% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $257.6K | 11,165 | 0.1% |
| Septerna Inc(SEPN) | COM | 81734D104 | $257.6K | 10,719 | 0.1% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $260.5K | 57,895 | 0.1% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $262.7K | 13,033 | 0.1% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $262.9K | 75,327 | 0.1% |
| Meiragtx Hldgs PLC(MGTX) | COM | G59665102 | $264.7K | 30,570 | 0.1% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $266.6K | 2,602 | 0.1% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $267.0K | 8,014 | 0.1% |